Composite Breast Augmentation

The prosthetic breast implant may be the single most important device ever developed in the field of plastic and reconstructive surgery. Despite half a century’s worth of technological advances, the revision rate for breast prostheses remains high.

Many revisions are performed for soft tissue related problems and not for failure related to the device per se. Soft tissue problems include capsular contracture and chronically atrophied and inadequate overlying tissue sometimes causing visibility of the device, a condition we define as “soft tissue failure”.

Simply stated, one of the major drawbacks of breast implants is their unnatural appearance when the overlying soft tissue volume to implant volume is out of balance.

Fat grafting to the breast has been met with increased enthusiasm since 2008 when the 1987 ASPS moratorium was reversed.  This event allowed the potential for surgeons to actively manage the soft tissue of the breast which has been initiated and performed by a group of independent practitioners.

While much of this early work with fat focused on core volume enhancement, there is a natural limitation to the projection achieved with fat alone, due to its soft nature.

Making the analogy to “mountains of sand”, breast projection using only fat comes at the cost of a wide breast footprint, often wider than desired. The purpose of the presention is to introduce a new paradigm in breast surgery – a combination of classic implant teachings and simultaneous management of the overlying soft tissue – a concept we define as composite breast surgery.

By incorporating both mediums, one may achieve the core volume projection of an implant complemented by the natural look and feel of a fat overlay.

MBN2018 from 12th to 15th December 2018, at City Life at MiCo Conference Center in Milan.

More info here.

Composite #Breast Augmentation #MBN2018 #PhillipBlondeel Condividi il Tweet
Phillip Blondeel MD

Professor and Chairman at Dept. of plastic surgery, Gent University Hospital.